Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
27,94 USD | +0,65% | -7,15% | -30,79% |
16/05 | Transcript : BridgeBio Pharma, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM | |
02/05 | Aandelen BridgeBio Pharma dalen na financiële resultaten Q1 | MT |
Omzet 2024 * | 385 mln. 355 mln. | Omzet 2025 * | 257 mln. 237 mln. | Marktkapitalisatie | 5,23 mld. 4,82 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -451 mln. -416 mln. | Nettowinst (verlies) 2025 * | -551 mln. -508 mln. | EV/omzet 2024 * | 16,5 x |
Nettoschuld 2024 * | 1,1 mld. 1,02 mld. | Nettoschuld 2025 * | 1,5 mld. 1,38 mld. | EV/omzet 2025 * | 26,1 x |
K/w-verhouding 2024 * |
-10,7
x | K/w-verhouding 2025 * |
-9,28
x | Werknemers | 553 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,93% |
Recentste transcriptie over BridgeBio Pharma, Inc.
1 dag | +0,65% | ||
1 week | -7,15% | ||
Lopende maand | +9,06% | ||
1 maand | +11,63% | ||
3 maanden | -17,82% | ||
6 maanden | -5,54% | ||
Lopend jaar | -30,79% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Neil Kumar
FOU | Founder | 45 | 01-01-15 |
Charles Homcy
FOU | Founder | 75 | 01-01-15 |
Founder | 73 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 01-03-16 |
Founder | 73 | 01-01-15 | |
Fred Hassan
BRD | Director/Board Member | 78 | 17-08-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.35% | 2 M€ | -.--% | ||
0.12% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0,00% | - | |
0.08% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 27,94 | +0,65% | 980 432 |
23-05-24 | 27,76 | -5,16% | 1 856 313 |
22-05-24 | 29,27 | -0,03% | 992 715 |
21-05-24 | 29,28 | -0,81% | 2 419 205 |
20-05-24 | 29,52 | -1,89% | 1 515 924 |
uitgestelde koers Nasdaq, 24 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-30,79% | 5,23 mld. | |
-2,00% | 90,02 mld. | |
-1,18% | 39,15 mld. | |
-15,83% | 31,71 mld. | |
+62,86% | 26,47 mld. | |
-21,68% | 14,34 mld. | |
-8,73% | 12,89 mld. | |
-15,05% | 11,18 mld. | |
-45,69% | 10,97 mld. | |
+4,94% | 8,94 mld. |